171 related articles for article (PubMed ID: 34438013)
21. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
[TBL] [Abstract][Full Text] [Related]
22. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.
Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK
Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518
[TBL] [Abstract][Full Text] [Related]
23. pH-triggered intracellular release from actively targeting polymer micelles.
Guo X; Shi C; Wang J; Di S; Zhou S
Biomaterials; 2013 Jun; 34(18):4544-54. PubMed ID: 23510854
[TBL] [Abstract][Full Text] [Related]
24. Dendronized nanoconjugates of lysine and folate for treatment of cancer.
Jain K; Gupta U; Jain NK
Eur J Pharm Biopharm; 2014 Aug; 87(3):500-9. PubMed ID: 24698808
[TBL] [Abstract][Full Text] [Related]
25. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
[TBL] [Abstract][Full Text] [Related]
26. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
27. pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells.
Debele TA; Yu LY; Yang CS; Shen YA; Lo CL
Biomacromolecules; 2018 Sep; 19(9):3725-3737. PubMed ID: 30044910
[TBL] [Abstract][Full Text] [Related]
28. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles.
Shi C; Guo X; Qu Q; Tang Z; Wang Y; Zhou S
Biomaterials; 2014 Oct; 35(30):8711-22. PubMed ID: 25002267
[TBL] [Abstract][Full Text] [Related]
29. In vivo studies of octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles loaded with doxorubicin for tumor-targeted delivery.
Zou A; Chen Y; Huo M; Wang J; Zhang Y; Zhou J; Zhang Q
J Pharm Sci; 2013 Jan; 102(1):126-35. PubMed ID: 23073894
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
Hu FQ; Liu LN; Du YZ; Yuan H
Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
[TBL] [Abstract][Full Text] [Related]
31. Nanovector Assembled from Natural Egg Yolk Lipids for Tumor-Targeted Delivery of Therapeutics.
Tang Z; Luo C; Jun Y; Yao M; Zhang M; He K; Jin L; Ma J; Chen S; Sun S; Tao M; Ding L; Sun X; Chen X; Zhang L; Gao Y; Wang QL
ACS Appl Mater Interfaces; 2020 Feb; 12(7):7984-7994. PubMed ID: 31971362
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effects of antitumor efficacy via mixed nano-size micelles of multifunctional Bletilla striata polysaccharide-based copolymer and D-α-tocopheryl polyethylene glycol succinate.
Liu Y; Wu J; Huang L; Qiao J; Wang N; Yu D; Zhang G; Yu S; Guan Q
Int J Biol Macromol; 2020 Jul; 154():499-510. PubMed ID: 32194114
[TBL] [Abstract][Full Text] [Related]
33. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
34. [Synthesis of folate modified chitosan-based nanomicelles and its
Liu L; Huang G; Bai H; Tang G
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):364-374. PubMed ID: 32762172
[TBL] [Abstract][Full Text] [Related]
35. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs.
Liu SQ; Wiradharma N; Gao SJ; Tong YW; Yang YY
Biomaterials; 2007 Mar; 28(7):1423-33. PubMed ID: 17141308
[TBL] [Abstract][Full Text] [Related]
36. Preparation and evaluation of reduction-responsive micelles based on disulfide-linked chondroitin sulfate A-tocopherol succinate for controlled antitumour drug release.
Cai S; Xie X; Yuan Q; Ding J; Meng L; Li J; He M; Li W; Yu J
J Pharm Pharmacol; 2021 Sep; 73(10):1405-1417. PubMed ID: 34254648
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs.
Kanwal U; Bukhari NI; Rana NF; Rehman M; Hussain K; Abbas N; Mehmood A; Raza A
Int J Nanomedicine; 2019; 14():1-15. PubMed ID: 30587981
[TBL] [Abstract][Full Text] [Related]
38. Preparation and In Vitro and In Vivo Antitumor Effects of VEGF Targeting Micelles.
Chang J; Yang Z; Li J; Jin Y; Gao Y; Sun Y; Li H; Yu T
Technol Cancer Res Treat; 2020; 19():1533033820957022. PubMed ID: 32912078
[TBL] [Abstract][Full Text] [Related]
39. Exogenous Vitamin C-Triggered Surface Charge Conversion of pH/Reduction-Responsive Micelles for the Enhanced Tumor-Specific Activity of Loaded Doxorubicin.
Wu Z; Chen B; Gan Z; Chen F; Luo X
Mol Pharm; 2020 Mar; 17(3):954-964. PubMed ID: 31977226
[TBL] [Abstract][Full Text] [Related]
40. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY
Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
